Arthneeti
All Q1 FY27 results →
E

Emami

Q1 FY27

Emami Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

Price₹376
Market cap₹16.4K Cr
P/E21.7
Updated16 Oct 2026
Read3 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned

The short version

Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Core domestic business growth expected to improve beyond current ~6% (Rajesh Sharma, page 13).

From Emami's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Moderate growth
  • Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13).
  • Management expects better growth in core business for the remainder of the year (Rajesh Sharma, pg 13).
  • Strategic investments portfolio grew 61% and expected to sustain similar growth going forward (Dhruv Aggarwal, pg 5).
  • Start-ups like The Man Company, Brillare showing strong momentum with plans for new launches and expansion (pg 7, 11).
  • Kesh King expected to achieve double-digit growth by year-end after mid-single-digit growth in Q1 (Mohan Goenka, pg 11).
  • International business faced challenges but expected significant recovery and growth in Q3 and Q4 (pg 7).

2 more points from Emami's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Emami said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Capex planned
  • Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.
  • The company plans further investments in strategic start-ups and fast-growing segments, with a committed management focus on such acquisitions.
  • The strategic investment division, including four start-ups, is expected to grow aggressively, targeting INR 750-800 crores revenue by year-end.
  • Emami is actively scouting for incremental acquisition opportunities alongside consolidating recent ones.
  • They are enhancing supply chain planning, inventory management, and distribution visibility and implementing AI-driven sales code systems to improve operational efficiency.

2 more points from Emami's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

See what Emami said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

Some related points can be inferred: - International business order execution faced challenges due to West Asia conflict and supply chain disruptions, especially for OTC pain management products. - The company is working to resolve regulatory approvals to move pain management products from India to Middle East markets.

2 more points from Emami's call on order book

Create a free account to keep reading this call

Emami — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹925 Cr, net profit ₹143 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Emami's management said in earlier quarters

Others in Personal Products this season

  • Dabur India Ltd (Q1 FY27)

    The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues. Key…

  • Bajaj Consumer (Q1 FY27)

    Recent quarters saw exponential growth: 20% YoY in FY26 and 28% YoY in Q1 FY27, partly due to prior price corrections and strategic actions (Nishita Shanklesha…

  • Colgate-Palmoliv (Q1 FY27)

    Premium segment is a key growth driver, growing 6 times faster than the market; significant opportunity remains as only 19% of toothpaste is currently premium…

  • Godrej Consumer (Q1 FY27)

    The company reported strong broad-based revenue growth of 19% YoY and volume growth of 9%, reflecting healthy demand. Key concall takeaways from Godrej…

Compare:vs Godrej Consumervs Dabur India Ltdvs Cupid

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Emami and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Emami Q1 FY27 results?

Domestic core business grew ~6% in Q1 FY27; hair care at 11%, skin care at 3% (Rajesh Sharma, pg 13). Core domestic business growth expected to improve beyond current ~6% (Rajesh Sharma, page 13).

What is Emami share price analysis?

Emami currently shows a below-average growth signal. The stock trades at a P/E of 21.7 with a market cap of ₹16,419 Cr. Investors should review the full earnings analysis for detailed insights.

Is Emami planning capital expenditure?

Emami has made a significant strategic investment, including about INR 500 crores in Axiom, funded internally from surplus cash.

Keep Emami on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.